We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Integrated Diagnostics Holdings Plc | LSE:IDHC | London | Ordinary Share | JE00BLKGSR75 | ORD USD0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.013 | 2.94% | 0.455 | 0.44 | 0.455 | 0.455 | 0.44 | 0.45 | 69,052 | 12:31:52 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/8/2022 12:00 | [...] 3.6m shares bought in total. | brucie5 | |
05/8/2022 11:00 | I had to blink, but there it is. 3.5m shares bought by the (PCA of) the CEO. 1. Details of PDMR / person closely associated with them ("PCA") a) Name Hena Holdings Ltd -------------------- 2. Reason for the notification -------------------- a) Position / status PCA of Dr Hend El Sherbini, Chief Executive Officer -------------------- b) Initial notification Initial Notification / amendment -------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor -------------------- a) Name Integrated Diagnostics Holding plc -------------------- b) LEI 2138007JN9NUWKKTS790 -------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted -------------------- a) Description IDH Ordinary Shares of $0.25 each of the financial instrument JE00BLKGSR75 Identification Code -------------------- b) Nature of the Purchase of shares transaction -------------------- c) Price(s) and Price(s) per share Volume(s) volume(s) USD 0.9000 3,562,737 ---------- -------------------- d) Aggregated information Aggregated volume 3,562,737 Price USD 0.9000 per share | brucie5 | |
04/8/2022 16:41 | Some big Director buying and the price drops 5%? | essential | |
03/8/2022 12:24 | Some very modest director buying. | brucie5 | |
01/8/2022 10:34 | Can't complain about dividend received, though. | brucie5 | |
31/7/2022 07:49 | I would have taken the extra 10% too if it was offered | johnthespacer | |
27/7/2022 16:51 | Interesting RNS. How worried should we be? Share price hasn't responded at all, so the company appears to have reassured. "Since the recommendation of the final dividend by IDH's board of directors and the subsequent declaration of the dividend by IDH's shareholders, the macro-economic situation globally and in Egypt has changed significantly. As such, despite its financial rigour and planning outlined above, IDH has encountered significant difficulties in sourcing the required amounts of USD to exchange for EGP for the purposes of making the Dividend Payment. This is largely as a consequence of the deteriorating broader macro-economic situation, including inflationary pressures and other consequences arising from the conflict in Ukraine, which has led to a scarcity of USD available in the foreign exchange markets for conversion to EGP. 2. Payment in full of dividend to minority shareholders today Despite the above-mentioned challenges, IDH has sourced sufficient USD to cover the full Dividend Payment due to all shareholders with the exception of its two largest shareholders, Hena Holdings Ltd ("Hena Holdings") and Actis IDH Limited ("Actis"), which have both agreed to defer their entitlement as described in section 3 of this release. IDH will begin paying the Dividend Payment due to all Eligible Shareholders (excluding Hena Holdings and Actis) as it falls due today (27 July 2022). 3. Deferral of dividend entitlement by IDH's two largest shareholders In light of these aforementioned difficulties in the foreign exchange market, IDH's two largest shareholders, Hena Holdings and Actis (the "Deferring Shareholders"), have agreed with IDH to defer the payment of their pro rata share of the Dividend Payment (being USD 17.7 million for Hena Holdings and USD 14.6 million for Actis, respectively) from 27 July 2022 to 27 January 2023 (the "Hena/Actis Deferral"). It is IDH's intention to seek to repay the sums due to both Deferring Shareholders as soon as it is practicably able to source the required USD currency. At this time, the Company expects the repayment to take place within the coming two months." | brucie5 | |
21/6/2022 16:34 | Blimey, what's happening here? Wonder if it's reflecting risk of instability in Egypt following rises in wheat prices... | brucie5 | |
07/6/2022 11:15 | Rare combi of dividend and quality. Obviously, with geographical risk, though this increasingly spread. I guess however, that Ukraine an wheat shortages may ad to tensions in its geographies. | brucie5 | |
28/4/2022 13:47 | Great company, just unloved. | rabiddog | |
28/4/2022 09:12 | Thanks for the heads up, Tomps - about time someone tried to promote it! | brucie5 | |
28/4/2022 09:08 | IDHC pitched in the latest episode of Sell It To The City Neil Cooper pitches Integrated Diagnostic Holdings (IDHC) to leading fund managers, Andy Brough, Judith MacKenzie and Stephen English at 25m47s in the latest PIWORLD Sell It To The city. Watch the video here: www.piworld.co.uk/ed Or listen to the podcast here: piworld.podbean.com/ | tomps2 | |
21/4/2022 13:17 | What no interest??? "Profitability came in at an all-time high, with adjusted EBITDA 1 growing 116% year-on-year to record EGP 2,530 million, and net profit recording a 145% year-on-year increase to reach EGP 1,493 million in FY 2021. In the final quarter of the year, IDH reported revenue of EGP 1,458 million, 48% above the previous year's figure, and net profit of EGP 345 million, up 47% from the comparable three month period of 2020. It is important to note that information in relation to the Company's full year results has been extracted from our audited annual report. Meanwhile, disclosures and statements in respect of quarterly information are unaudited. In light of IDH's outstanding performance for the twelve months ended 31 December 2021, IDH's board of directors has recommended a dividend distribution of EGP 2.17 per share, or EGP 1.3 billion in aggregate, to shareholders (exact US dollar amount is subject to the exchange rate at the time of the upstreaming from the subsidiaries to the holding company). This represents a significant increase compared to a final dividend of US$ 29.1 million distributed for the previous financial year." | brucie5 | |
07/1/2022 12:11 | Anyone else noticing/enjoying this chart? Given all that's going down in Kazakhstan atm, with implications for dividend favourites CAML and STCM, IDHC looks a relatively tranquil option... | brucie5 | |
28/12/2021 08:22 | Thanks Dave, interesting article on several levels. | brucie5 | |
27/12/2021 10:34 | Mentioned here- | davebowler | |
20/12/2021 15:08 | Yeah I picked it up off stocko as well. Chart looks great as you say. | rabiddog | |
20/12/2021 14:09 | Yes, I hear a lot of peeps saying that this is too risky for their folios, but if you hold shares like CEY, WEN and FXPO, which I currently do, then adding a bit more geographical diversity may not be foolish, even if there is of course, country specific risk. IDHC ranks very highly on Stocko. I hope to be a holder for some time, unless I see good reason for selling. Chart also looks positive, btw, though not sure how much you can read into that... | brucie5 | |
20/12/2021 13:54 | Yeah still here. If it’s hq wasn’t in Egypt would be double the price…but it is lol. | rabiddog | |
20/12/2021 13:37 | Maiden stake here. Been watching for months. Sold down my GSK profits and almost double my dividends. Anyone else holding? | brucie5 | |
07/10/2021 12:39 | Many thanks for those pointers, the more I looked and considered the backdrop, the more I liked.I'll take a look at Jack Brumby's piece and the auditor's note. Cheers, tightfist | tightfist | |
06/10/2021 19:35 | If you have stockopedia, Jack brumby did an excellent write up at the beginning of August…kicked off with this quote If you focus on the financial data alone, few listed companies can compete with the kind of consistent double digit growth rates and profit margins notched up by Integrated Diagnostics Holdings (LON:IDHC) - yet this company trades on just 13.8x forecast earnings and is expected to pay out a generous 5.7% dividend. The gotchas are mainly to do with geography/ jurisdictions and also note that the auditors left this year(Kpmg) sounds like they had a fallout with management. Pwc have stepped in so watching brief for now. | rabiddog | |
06/10/2021 17:14 | Since early September the analysts forecasts (according to Stockopedia) have been shooting-up, although there is now a dip in forecast revenue and eps within 2022E. The yield is attractive too at 7%.Time to get my head around investing once again in Egypt..... Any thoughts there, RabidDog? | tightfist | |
02/9/2021 11:06 | Good H1 results today. Although there has been an uplift in the share price it is difficult to work out what the bottom line would be without the impact of Covid which creates some uncertainty as to how one values the company. However it is stated that non Covid test revenue has grown 38% on H1 2020 but the prior period had been affected by reduced testing so comparing with H1 2019 shows underlying non Covid growth of 17%. | valhamos |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions